Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-13

Clinical Trial Update: Outpatient Neutropenic Diet Study [Phase 2]

View source ↗

Summary

Phase 2 outpatient neutropenic diet trial sponsored by MD Anderson Cancer Center for leukemia with neutropenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Neutropenia | Phase 2 | Status: TERMINATED